PDB Short entry for 2X6D HEADER TRANSFERASE 17-FEB-10 2X6D TITLE AURORA-A BOUND TO AN INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE 6; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: CATALYTIC DOMAIN, RESIDUES 122-403; COMPND 5 SYNONYM: AURORA-A, AURORA KINASE A, SERINE/THREONINE-PROTEIN KINASE COMPND 6 AURORA-A, SERINE/THREONINE KINASE 15, AURORA/IPL1-RELATED KINASE 1, COMPND 7 AURORA-RELATED KINASE 1, ARK-1, HARK-1, BREAST TUMOR-AMPLIFIED COMPND 8 KINASE; COMPND 9 EC: 2.7.11.1; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) KEYWDS TRANSFERASE, MITOSIS EXPDTA X-RAY DIFFRACTION AUTHOR M.KOSMOPOULOU,R.BAYLISS REVDAT 5 20-DEC-23 2X6D 1 REMARK REVDAT 4 30-OCT-19 2X6D 1 REMARK LINK REVDAT 3 28-FEB-18 2X6D 1 JRNL REVDAT 2 20-APR-11 2X6D 1 JRNL REMARK DBREF SEQADV REVDAT 1 07-JUL-10 2X6D 0 JRNL AUTH V.BAVETSIAS,J.M.LARGE,C.SUN,N.BOULOC,M.KOSMOPOULOU, JRNL AUTH 2 M.MATTEUCCI,N.E.WILSHER,V.MARTINS,J.REYNISSON,B.ATRASH, JRNL AUTH 3 A.FAISAL,F.URBAN,M.VALENTI,A.DE HAVEN BRANDON,G.BOX, JRNL AUTH 4 F.I.RAYNAUD,P.WORKMAN,S.A.ECCLES,R.BAYLISS,J.BLAGG, JRNL AUTH 5 S.LINARDOPOULOS,E.MCDONALD JRNL TITL IMIDAZO[4,5-B]PYRIDINE DERIVATIVES AS INHIBITORS OF AURORA JRNL TITL 2 KINASES: LEAD OPTIMIZATION STUDIES TOWARD THE IDENTIFICATION JRNL TITL 3 OF AN ORALLY BIOAVAILABLE PRECLINICAL DEVELOPMENT CANDIDATE. JRNL REF J. MED. CHEM. V. 53 5213 2010 JRNL REFN ISSN 1520-4804 JRNL PMID 20565112 JRNL DOI 10.1021/JM100262J REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.84 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.400 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 8903 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.220 REMARK 3 R VALUE (WORKING SET) : 0.217 REMARK 3 FREE R VALUE : 0.264 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT : 423 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 19.8425 - 4.0251 1.00 2969 143 0.2063 0.2416 REMARK 3 2 4.0251 - 3.1992 1.00 2784 142 0.1957 0.2551 REMARK 3 3 3.1992 - 2.7960 1.00 2727 138 0.2466 0.3404 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : 0.36 REMARK 3 B_SOL : 56.80 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.440 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 25.860 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 65.61 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.03780 REMARK 3 B22 (A**2) : -0.03780 REMARK 3 B33 (A**2) : 0.07560 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.019 2214 REMARK 3 ANGLE : 2.193 3005 REMARK 3 CHIRALITY : 0.118 315 REMARK 3 PLANARITY : 0.011 382 REMARK 3 DIHEDRAL : 21.197 812 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2X6D COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 17-FEB-10. REMARK 100 THE DEPOSITION ID IS D_1290042954. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.934 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 9000 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.790 REMARK 200 RESOLUTION RANGE LOW (A) : 86.100 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 6.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 4.200 REMARK 200 R MERGE (I) : 0.06000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 9.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.79 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.95 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.7 REMARK 200 DATA REDUNDANCY IN SHELL : 4.20 REMARK 200 R MERGE FOR SHELL (I) : 0.18000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 4.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 1MQ4 REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.17 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.70 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100MM BICINE PH 9.0, 2.0 M AMMONIUM REMARK 280 SULFATE REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+5/6 REMARK 290 6555 X-Y,X,Z+1/6 REMARK 290 7555 Y,X,-Z+1/3 REMARK 290 8555 X-Y,-Y,-Z REMARK 290 9555 -X,-X+Y,-Z+2/3 REMARK 290 10555 -Y,-X,-Z+5/6 REMARK 290 11555 -X+Y,Y,-Z+1/2 REMARK 290 12555 X,X-Y,-Z+1/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 57.33067 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 114.66133 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 85.99600 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 143.32667 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 28.66533 REMARK 290 SMTRY1 7 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 7 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 57.33067 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 9 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 9 0.000000 0.000000 -1.000000 114.66133 REMARK 290 SMTRY1 10 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 10 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 10 0.000000 0.000000 -1.000000 143.32667 REMARK 290 SMTRY1 11 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 11 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 11 0.000000 0.000000 -1.000000 85.99600 REMARK 290 SMTRY1 12 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 12 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 12 0.000000 0.000000 -1.000000 28.66533 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 119 REMARK 465 ALA A 120 REMARK 465 MET A 121 REMARK 465 GLU A 122 REMARK 465 SER A 123 REMARK 465 LYS A 124 REMARK 465 LYS A 125 REMARK 465 LYS A 171 REMARK 465 ALA A 172 REMARK 465 GLY A 173 REMARK 465 VAL A 174 REMARK 465 ARG A 286 REMARK 465 THR A 287 REMARK 465 THR A 288 REMARK 465 LEU A 289 REMARK 465 LYS A 389 REMARK 465 PRO A 390 REMARK 465 SER A 391 REMARK 465 ASN A 392 REMARK 465 CYS A 393 REMARK 465 GLN A 394 REMARK 465 ASN A 395 REMARK 465 LYS A 396 REMARK 465 GLU A 397 REMARK 465 SER A 398 REMARK 465 ALA A 399 REMARK 465 SER A 400 REMARK 465 LYS A 401 REMARK 465 GLN A 402 REMARK 465 SER A 403 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 126 CG CD NE CZ NH1 NH2 REMARK 470 GLN A 127 CG CD OE1 NE2 REMARK 470 GLU A 183 CG CD OE1 OE2 REMARK 470 ARG A 285 CB CG CD NE CZ NH1 NH2 REMARK 470 LYS A 339 CG CD CE NZ REMARK 470 ARG A 375 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE2 GLU A 302 NH2 ARG A 304 1.83 REMARK 500 O VAL A 182 OG SER A 186 2.04 REMARK 500 OE2 GLU A 221 NH1 ARG A 232 2.15 REMARK 500 NH2 ARG A 357 O HOH A 2027 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OE2 GLU A 175 NH1 ARG A 179 10555 1.12 REMARK 500 CD GLU A 175 NH1 ARG A 179 10555 1.15 REMARK 500 OE1 GLU A 175 NH2 ARG A 179 10555 1.23 REMARK 500 OE1 GLU A 175 CZ ARG A 179 10555 1.33 REMARK 500 OE1 GLU A 175 NH1 ARG A 179 10555 1.61 REMARK 500 CD GLU A 175 CZ ARG A 179 10555 1.89 REMARK 500 OE1 GLU A 336 OE1 GLU A 336 12566 2.08 REMARK 500 OE1 GLU A 336 OE2 GLU A 336 12566 2.08 REMARK 500 NZ LYS A 153 OD2 ASP A 350 8666 2.08 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 SER A 226 CA SER A 226 C 0.214 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 GLU A 175 OE1 - CD - OE2 ANGL. DEV. = 12.2 DEGREES REMARK 500 GLU A 175 CG - CD - OE1 ANGL. DEV. = -17.0 DEGREES REMARK 500 HIS A 176 N - CA - C ANGL. DEV. = 16.4 DEGREES REMARK 500 ARG A 179 NH1 - CZ - NH2 ANGL. DEV. = 11.1 DEGREES REMARK 500 ARG A 179 NE - CZ - NH1 ANGL. DEV. = -13.6 DEGREES REMARK 500 PRO A 297 C - N - CA ANGL. DEV. = 9.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 169 99.68 -40.18 REMARK 500 PHE A 200 143.08 -174.89 REMARK 500 ALA A 203 16.44 85.93 REMARK 500 THR A 204 -19.00 -145.79 REMARK 500 ARG A 255 -4.79 74.62 REMARK 500 ASP A 256 48.03 -149.05 REMARK 500 ASP A 274 63.22 66.11 REMARK 500 PHE A 275 41.16 -78.84 REMARK 500 ASP A 307 -157.94 -135.97 REMARK 500 GLU A 308 -7.63 -59.28 REMARK 500 HIS A 380 121.43 -39.63 REMARK 500 SER A 387 -166.34 -72.34 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 SER A 226 -10.01 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1389 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1390 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE X6D A 1391 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1MUO RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF AURORA-2, AN ONCOGENIC SERINE-THREONINE KINASE REMARK 900 RELATED ID: 2J50 RELATED DB: PDB REMARK 900 STRUCTURE OF AURORA-2 IN COMPLEX WITH PHA-739358 REMARK 900 RELATED ID: 2W1D RELATED DB: PDB REMARK 900 STRUCTURE DETERMINATION OF AURORA KINASE IN COMPLEX WITH INHIBITOR REMARK 900 RELATED ID: 1OL6 RELATED DB: PDB REMARK 900 STRUCTURE OF UNPHOSPHORYLATED D274N MUTANT OF AURORA-A REMARK 900 RELATED ID: 2BMC RELATED DB: PDB REMARK 900 AURORA-2 T287D T288D COMPLEXED WITH PHA-680632 REMARK 900 RELATED ID: 2C6E RELATED DB: PDB REMARK 900 AURORA A KINASE ACTIVATED MUTANT (T287D) IN COMPLEX WITH A 5- REMARK 900 AMINOPYRIMIDINYL QUINAZOLINE INHIBITOR REMARK 900 RELATED ID: 2J4Z RELATED DB: PDB REMARK 900 STRUCTURE OF AURORA-2 IN COMPLEX WITH PHA-680626 REMARK 900 RELATED ID: 1OL5 RELATED DB: PDB REMARK 900 STRUCTURE OF AURORA-A 122-403, PHOSPHORYLATED ON THR287, THR288 AND REMARK 900 BOUND TO TPX2 1-43 REMARK 900 RELATED ID: 2C6D RELATED DB: PDB REMARK 900 AURORA A KINASE ACTIVATED MUTANT (T287D) IN COMPLEX WITH ADPNP REMARK 900 RELATED ID: 2WTW RELATED DB: PDB REMARK 900 AURORA-A INHIBITOR STRUCTURE (2ND CRYSTAL FORM) REMARK 900 RELATED ID: 2WQE RELATED DB: PDB REMARK 900 STRUCTURE OF S155R AURORA-A SOMATIC MUTANT REMARK 900 RELATED ID: 2W1C RELATED DB: PDB REMARK 900 STRUCTURE DETERMINATION OF AURORA KINASE IN COMPLEX WITH INHIBITOR REMARK 900 RELATED ID: 2W1G RELATED DB: PDB REMARK 900 STRUCTURE DETERMINATION OF AURORA KINASE IN COMPLEX WITH INHIBITOR REMARK 900 RELATED ID: 2WTV RELATED DB: PDB REMARK 900 AURORA-A INHIBITOR STRUCTURE REMARK 900 RELATED ID: 1OL7 RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN AURORA-A 122-403 PHOSPHORYLATED ON THR287, THR288 REMARK 900 RELATED ID: 2W1E RELATED DB: PDB REMARK 900 STRUCTURE DETERMINATION OF AURORA KINASE IN COMPLEX WITH INHIBITOR REMARK 900 RELATED ID: 2W1F RELATED DB: PDB REMARK 900 STRUCTURE DETERMINATION OF AURORA KINASE IN COMPLEX WITH INHIBITOR REMARK 900 RELATED ID: 1MQ4 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF AURORA-A PROTEIN KINASE REMARK 900 RELATED ID: 2X6E RELATED DB: PDB REMARK 900 AURORA-A BOUND TO AN INHIBITOR REMARK 999 REMARK 999 SEQUENCE REMARK 999 N-TERMINAL 'GAM' APPENDED FROM VECTOR SEQUENCE DBREF 2X6D A 122 403 UNP O14965 STK6_HUMAN 122 403 SEQADV 2X6D GLY A 119 UNP O14965 EXPRESSION TAG SEQADV 2X6D ALA A 120 UNP O14965 EXPRESSION TAG SEQADV 2X6D MET A 121 UNP O14965 EXPRESSION TAG SEQRES 1 A 285 GLY ALA MET GLU SER LYS LYS ARG GLN TRP ALA LEU GLU SEQRES 2 A 285 ASP PHE GLU ILE GLY ARG PRO LEU GLY LYS GLY LYS PHE SEQRES 3 A 285 GLY ASN VAL TYR LEU ALA ARG GLU LYS GLN SER LYS PHE SEQRES 4 A 285 ILE LEU ALA LEU LYS VAL LEU PHE LYS ALA GLN LEU GLU SEQRES 5 A 285 LYS ALA GLY VAL GLU HIS GLN LEU ARG ARG GLU VAL GLU SEQRES 6 A 285 ILE GLN SER HIS LEU ARG HIS PRO ASN ILE LEU ARG LEU SEQRES 7 A 285 TYR GLY TYR PHE HIS ASP ALA THR ARG VAL TYR LEU ILE SEQRES 8 A 285 LEU GLU TYR ALA PRO LEU GLY THR VAL TYR ARG GLU LEU SEQRES 9 A 285 GLN LYS LEU SER LYS PHE ASP GLU GLN ARG THR ALA THR SEQRES 10 A 285 TYR ILE THR GLU LEU ALA ASN ALA LEU SER TYR CYS HIS SEQRES 11 A 285 SER LYS ARG VAL ILE HIS ARG ASP ILE LYS PRO GLU ASN SEQRES 12 A 285 LEU LEU LEU GLY SER ALA GLY GLU LEU LYS ILE ALA ASP SEQRES 13 A 285 PHE GLY TRP SER VAL HIS ALA PRO SER SER ARG ARG THR SEQRES 14 A 285 THR LEU CYS GLY THR LEU ASP TYR LEU PRO PRO GLU MET SEQRES 15 A 285 ILE GLU GLY ARG MET HIS ASP GLU LYS VAL ASP LEU TRP SEQRES 16 A 285 SER LEU GLY VAL LEU CYS TYR GLU PHE LEU VAL GLY LYS SEQRES 17 A 285 PRO PRO PHE GLU ALA ASN THR TYR GLN GLU THR TYR LYS SEQRES 18 A 285 ARG ILE SER ARG VAL GLU PHE THR PHE PRO ASP PHE VAL SEQRES 19 A 285 THR GLU GLY ALA ARG ASP LEU ILE SER ARG LEU LEU LYS SEQRES 20 A 285 HIS ASN PRO SER GLN ARG PRO MET LEU ARG GLU VAL LEU SEQRES 21 A 285 GLU HIS PRO TRP ILE THR ALA ASN SER SER LYS PRO SER SEQRES 22 A 285 ASN CYS GLN ASN LYS GLU SER ALA SER LYS GLN SER HET SO4 A1389 5 HET SO4 A1390 5 HET X6D A1391 37 HETNAM SO4 SULFATE ION HETNAM X6D 6-BROMO-7-[4-(4-CHLOROBENZYL)PIPERAZIN-1-YL]-2-[4- HETNAM 2 X6D (MORPHOLIN-4-YLMETHYL)PHENYL]-3H-IMIDAZO[4,5- HETNAM 3 X6D B]PYRIDINE HETSYN X6D CTT137444 FORMUL 2 SO4 2(O4 S 2-) FORMUL 4 X6D C28 H30 BR CL N6 O FORMUL 5 HOH *27(H2 O) HELIX 1 1 ALA A 129 GLU A 131 5 3 HELIX 2 2 GLN A 177 HIS A 187 1 11 HELIX 3 3 THR A 217 LEU A 225 1 9 HELIX 4 4 ASP A 229 LYS A 250 1 22 HELIX 5 5 LYS A 258 GLU A 260 5 3 HELIX 6 6 ASP A 274 SER A 278 5 5 HELIX 7 7 PRO A 297 GLU A 302 1 6 HELIX 8 8 GLU A 308 GLY A 325 1 18 HELIX 9 9 THR A 333 ARG A 343 1 11 HELIX 10 10 THR A 353 LEU A 364 1 12 HELIX 11 11 ASN A 367 ARG A 371 5 5 HELIX 12 12 MET A 373 HIS A 380 1 8 HELIX 13 13 HIS A 380 SER A 387 1 8 SHEET 1 AA 5 PHE A 133 LYS A 141 0 SHEET 2 AA 5 GLY A 145 GLU A 152 -1 O VAL A 147 N LEU A 139 SHEET 3 AA 5 ILE A 158 PHE A 165 -1 O LEU A 159 N ALA A 150 SHEET 4 AA 5 ARG A 205 LEU A 210 -1 O VAL A 206 N LEU A 164 SHEET 5 AA 5 LEU A 196 HIS A 201 -1 N TYR A 197 O ILE A 209 SHEET 1 AB 2 VAL A 252 ILE A 253 0 SHEET 2 AB 2 VAL A 279 HIS A 280 -1 O VAL A 279 N ILE A 253 SHEET 1 AC 2 LEU A 262 LEU A 264 0 SHEET 2 AC 2 LEU A 270 ILE A 272 -1 O LYS A 271 N LEU A 263 CISPEP 1 ALA A 281 PRO A 282 0 1.98 SITE 1 AC1 5 ARG A 220 LYS A 365 HIS A 366 ASN A 367 SITE 2 AC1 5 X6D A1391 SITE 1 AC2 1 SER A 266 SITE 1 AC3 13 LEU A 139 GLY A 140 LYS A 141 GLY A 145 SITE 2 AC3 13 ASN A 146 ALA A 160 GLU A 211 TYR A 212 SITE 3 AC3 13 ALA A 213 GLY A 216 ARG A 220 HIS A 366 SITE 4 AC3 13 SO4 A1389 CRYST1 81.569 81.569 171.992 90.00 90.00 120.00 P 61 2 2 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012260 0.007078 0.000000 0.00000 SCALE2 0.000000 0.014156 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005814 0.00000